These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 20884698)

  • 1. Chronic kidney disease and risk of major cardiovascular disease and non-vascular mortality: prospective population based cohort study.
    Di Angelantonio E; Chowdhury R; Sarwar N; Aspelund T; Danesh J; Gudnason V
    BMJ; 2010 Sep; 341():c4986. PubMed ID: 20884698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relation between Kidney Length and Cardiovascular and Renal Risk in High-Risk Patients.
    van der Sande NGC; Visseren FLJ; van der Graaf Y; Nathoe HM; de Borst GJ; Leiner T; Blankestijn PJ;
    Clin J Am Soc Nephrol; 2017 Jun; 12(6):921-928. PubMed ID: 28487344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Body mass index modifies the risk of cardiovascular death in proteinuric chronic kidney disease.
    Obermayr RP; Temml C; Gutjahr G; Kainz A; Klauser-Braun R; Függer R; Oberbauer R
    Nephrol Dial Transplant; 2009 Aug; 24(8):2421-8. PubMed ID: 19244226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CKD and mortality risk in older people: a community-based population study in the United Kingdom.
    Roderick PJ; Atkins RJ; Smeeth L; Mylne A; Nitsch DD; Hubbard RB; Bulpitt CJ; Fletcher AE
    Am J Kidney Dis; 2009 Jun; 53(6):950-60. PubMed ID: 19394727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kidney function and risk of cardiovascular disease and mortality in women: a prospective cohort study.
    Kurth T; de Jong PE; Cook NR; Buring JE; Ridker PM
    BMJ; 2009 Jun; 338():b2392. PubMed ID: 19564178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antihypertensive treatment and risk of cardiovascular mortality in patients with chronic kidney disease diagnosed based on the presence of proteinuria and renal function: A large longitudinal study in Japan.
    Nagai K; Yamagata K; Iseki K; Moriyama T; Tsuruya K; Fujimoto S; Narita I; Konta T; Kondo M; Kasahara M; Shibagaki Y; Asahi K; Watanabe T
    PLoS One; 2019; 14(12):e0225812. PubMed ID: 31800605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Migraine with aura and risk of cardiovascular and all cause mortality in men and women: prospective cohort study.
    Gudmundsson LS; Scher AI; Aspelund T; Eliasson JH; Johannsson M; Thorgeirsson G; Launer L; Gudnason V
    BMJ; 2010 Aug; 341():c3966. PubMed ID: 20736269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mild decrease in estimated glomerular filtration rate and proteinuria are associated with all-cause and cardiovascular mortality in the general population.
    Oh SW; Baek SH; Kim YC; Goo HS; Heo NJ; Na KY; Chae DW; Kim S; Chin HJ
    Nephrol Dial Transplant; 2012 Jun; 27(6):2284-90. PubMed ID: 22140122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of serum bicarbonate with risk of renal and cardiovascular outcomes in CKD: a report from the Chronic Renal Insufficiency Cohort (CRIC) study.
    Dobre M; Yang W; Chen J; Drawz P; Hamm LL; Horwitz E; Hostetter T; Jaar B; Lora CM; Nessel L; Ojo A; Scialla J; Steigerwalt S; Teal V; Wolf M; Rahman M;
    Am J Kidney Dis; 2013 Oct; 62(4):670-8. PubMed ID: 23489677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reclassification of chronic kidney disease patients for end-stage renal disease risk by proteinuria indexed to estimated glomerular filtration rate: multicentre prospective study in nephrology clinics.
    Provenzano M; Chiodini P; Minutolo R; Zoccali C; Bellizzi V; Conte G; Locatelli F; Tripepi G; Del Vecchio L; Mallamaci F; Di Micco L; Russo D; Heerspink HJL; De Nicola L
    Nephrol Dial Transplant; 2020 Jan; 35(1):138-147. PubMed ID: 30053127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble Urokinase Plasminogen Activator Receptor Predicts Cardiovascular Events, Kidney Function Decline, and Mortality in Patients With Type 1 Diabetes.
    Rotbain Curovic V; Theilade S; Winther SA; Tofte N; Eugen-Olsen J; Persson F; Hansen TW; Jeppesen J; Rossing P
    Diabetes Care; 2019 Jun; 42(6):1112-1119. PubMed ID: 30885954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associations of resting heart rate with insulin resistance, cardiovascular events and mortality in chronic kidney disease.
    Beddhu S; Nigwekar SU; Ma X; Greene T
    Nephrol Dial Transplant; 2009 Aug; 24(8):2482-8. PubMed ID: 19307229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitamin D status and mortality in chronic kidney disease.
    Pilz S; Tomaschitz A; Friedl C; Amrein K; Drechsler C; Ritz E; Boehm BO; Grammer TB; März W
    Nephrol Dial Transplant; 2011 Nov; 26(11):3603-9. PubMed ID: 21378153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease.
    Isakova T; Xie H; Yang W; Xie D; Anderson AH; Scialla J; Wahl P; Gutiérrez OM; Steigerwalt S; He J; Schwartz S; Lo J; Ojo A; Sondheimer J; Hsu CY; Lash J; Leonard M; Kusek JW; Feldman HI; Wolf M;
    JAMA; 2011 Jun; 305(23):2432-9. PubMed ID: 21673295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Smoking and Adverse Outcomes in Patients With CKD: The Study of Heart and Renal Protection (SHARP).
    Staplin N; Haynes R; Herrington WG; Reith C; Cass A; Fellström B; Jiang L; Kasiske BL; Krane V; Levin A; Walker R; Wanner C; Wheeler DC; Landray MJ; Baigent C; Emberson J;
    Am J Kidney Dis; 2016 Sep; 68(3):371-80. PubMed ID: 27118687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Echocardiography to predict adverse cardiac and vascular events in patients with severe chronic kidney disease (stage 4): a prospective study.
    Lesaffre F; Wynckel A; Nazeyrollas P; Rieu P; Metz D
    Arch Cardiovasc Dis; 2013 Apr; 106(4):220-7. PubMed ID: 23706368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risks of Adverse Events in Advanced CKD: The Chronic Renal Insufficiency Cohort (CRIC) Study.
    Grams ME; Yang W; Rebholz CM; Wang X; Porter AC; Inker LA; Horwitz E; Sondheimer JH; Hamm LL; He J; Weir MR; Jaar BG; Shafi T; Appel LJ; Hsu CY;
    Am J Kidney Dis; 2017 Sep; 70(3):337-346. PubMed ID: 28366517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging cardiovascular risk factors that account for a significant portion of attributable mortality risk in chronic kidney disease.
    Shishehbor MH; Oliveira LP; Lauer MS; Sprecher DL; Wolski K; Cho L; Hoogwerf BJ; Hazen SL
    Am J Cardiol; 2008 Jun; 101(12):1741-6. PubMed ID: 18549850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimated glomerular filtration rate and albuminuria for prediction of cardiovascular outcomes: a collaborative meta-analysis of individual participant data.
    Matsushita K; Coresh J; Sang Y; Chalmers J; Fox C; Guallar E; Jafar T; Jassal SK; Landman GW; Muntner P; Roderick P; Sairenchi T; Schöttker B; Shankar A; Shlipak M; Tonelli M; Townend J; van Zuilen A; Yamagishi K; Yamashita K; Gansevoort R; Sarnak M; Warnock DG; Woodward M; Ärnlöv J;
    Lancet Diabetes Endocrinol; 2015 Jul; 3(7):514-25. PubMed ID: 26028594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced glomerular filtration rate and its association with clinical outcome in older patients at risk of vascular events: secondary analysis.
    Ford I; Bezlyak V; Stott DJ; Sattar N; Packard CJ; Perry I; Buckley BM; Jukema JW; de Craen AJ; Westendorp RG; Shepherd J
    PLoS Med; 2009 Jan; 6(1):e16. PubMed ID: 19166266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.